Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

Title
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
Authors
Keywords
Patisiran, RNA interference, Transthyretin-mediated familial amyloidotic polyneuropathy, Polyneuropathy, Hereditary disease, Genetic mutation, Phase II, Clinical trial
Journal
Orphanet Journal of Rare Diseases
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-03
DOI
10.1186/s13023-015-0326-6

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started